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stretch the non-calcified sectorial segment of the vessel 
lumen while creating a neointimal cap overlying the cal-
cified plaques thereby refurbishing the endoluminal lin-
ing at that specific site (Fig. 1). Through its sealing func-
tion, Absorb further isolates the calcified plaques from the 
lumen and the flowing blood.
Bioresorbable scaffolds may be a treatment option for 
calcified plaques by inducing a neointimal cap at follow 
up. The advantage of biodegradable device compared to 
the metallic stent is temporary vessel scaffolding which 
reduces the inflammatory response in treated segments 
at follow up. Reduced inflammation with re-capping may 
decrease the vulnerability risk of the plaques.
Optical coherence tomography (OCT) has been the imag-
ing technique for detection of scaffold malapposition dur-
ing implantation, the method of choice at follow up for 
assessing strut resorption and measurement of cap thick-
ness overlying atherosclerotic plaques [1]. Bioresorbable 
scaffold (BRS) has the capability of sealing plaque by cre-
ating a neointimal cap [2]. Herewith, we present three cases 
from Absorb Cohort-B trial exhibiting the evolution of 
neointimal tissue overlying calcified plaques at 5-year post-
implantation. The scaffolds were assessed on OCT after 
implantation, at 1-, 3- and 5-year follow ups.
Coronary artery calcification is a risk factor for coro-
nary adverse events [3]. Despite lower radial strength as 
compared to the metallic equivalent, Absorb is capable to 
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Fig. 1  Three cases from Absorb Cohort-B trial demonstrate calci-
fied plaques covered by scaffold struts after post implantation (A1, 
B1, C1) in optical coherence tomography images. At 1-year (A2, B2, 
C2) and 3-year follow-ups (A3, B3, C3), scaffold struts and progress 
of neointima at 1-year and at 3-years, sealing the calcified plaques, 
could be observed. At 5-year follow up (A4, B4, C4), after resorption 
of the struts has been completed, the calcified plaques are definitely 
sealed by the overlying neointimal tissue that has a tendency to shrink 
and reflect more intensively (min CT minimum cap thickness)
